Jaguar Health (JAGX) Net Margin Growth (3y) (2018 - 2026)

Jaguar Health (JAGX) Net Margin Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Nanobiotix 1,774.59 Bn 1,774.53 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
3 BeOne Medicines 473.53 Bn 468.74 Bn 1.35 Bn 9,283.00
4 Vertex Pharmaceuticals 123.91 Bn 116.66 Bn 2.59 Bn 506.00
5 Regeneron Pharmaceuticals 71.79 Bn 63.04 Bn 3.31 Bn -569.00
6 Belite Bio 62.15 Bn 62.15 Bn - -
7 Argenx Se 54.75 Bn 49.57 Bn 1.41 Bn -471.00
8 Alnylam Pharmaceuticals 38.10 Bn 35.10 Bn 959.66 Mn 7,218.00
9 Revolution Medicines 36.11 Bn 36.11 Bn - -
10 Jaguar Health 509,443.80 -9.55 Mn 19.11 Mn 2.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.71 Mn
Dec 31, 2025 2.30 Mn
Sep 30, 2025 8,668.00
Jun 30, 2025 -3,380.00
Mar 31, 2025 8.95 Mn
Dec 31, 2024 39,647.00
Sep 30, 2024 166,001.00
Jun 30, 2024 336,646.00
Mar 31, 2024 60,169.00
Dec 31, 2023 4,245.00
Sep 30, 2023 6.33 Mn
Jun 30, 2023 7.52 Mn
Mar 31, 2023 -2.61 Mn
Dec 31, 2022 -2.32 Mn
Sep 30, 2022 80,110.00
Jun 30, 2022 65,945.00
Mar 31, 2022 -8.94 Mn
Dec 31, 2021 4,244.00
Sep 30, 2021 -144,021.00
Jun 30, 2021 -273,638.00